These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
144 related items for PubMed ID: 20530022
21. The BARI 2D study: a randomised trial of therapies for type 2 diabetes and coronary artery disease. Rutter MK, Nesto RW. Diab Vasc Dis Res; 2010 Jan; 7(1):69-72. PubMed ID: 20368235 [Abstract] [Full Text] [Related]
25. One-year outcomes of coronary artery bypass graft surgery versus percutaneous coronary intervention with multiple stenting for multisystem disease: a meta-analysis of individual patient data from randomized clinical trials. Mercado N, Wijns W, Serruys PW, Sigwart U, Flather MD, Stables RH, O'Neill WW, Rodriguez A, Lemos PA, Hueb WA, Gersh BJ, Booth J, Boersma E. J Thorac Cardiovasc Surg; 2005 Aug; 130(2):512-9. PubMed ID: 16077421 [Abstract] [Full Text] [Related]
26. The Coronary Artery Revascularisation in Diabetes (CARDia) trial: background, aims, and design. Kapur A, Malik IS, Bagger JP, Anderson JR, Kooner JS, Thomas M, Punjabi P, Mayet J, Millane T, Goedicke J, Jamrozik K, de Belder MA, Hall RJ, Beatt KJ. Am Heart J; 2005 Jan; 149(1):13-9. PubMed ID: 15660030 [Abstract] [Full Text] [Related]
27. Randomized clinical trials: do they really make a difference? BARI and diabetes mellitus. Holmes DR. Cathet Cardiovasc Diagn; 1996 Mar; 37(3):351-2. PubMed ID: 8974825 [No Abstract] [Full Text] [Related]
28. Coronary revascularisation in the patient with diabetes: balancing risk and benefit. Rutter MK, Nesto RW. Heart; 2010 Sep; 96(18):1436-40. PubMed ID: 20813726 [No Abstract] [Full Text] [Related]
32. The impact of revascularization on mortality in patients with nonacute coronary artery disease. Jeremias A, Kaul S, Rosengart TK, Gruberg L, Brown DL. Am J Med; 2009 Feb; 122(2):152-61. PubMed ID: 19185092 [Abstract] [Full Text] [Related]
33. Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial. Kapur A, Hall RJ, Malik IS, Qureshi AC, Butts J, de Belder M, Baumbach A, Angelini G, de Belder A, Oldroyd KG, Flather M, Roughton M, Nihoyannopoulos P, Bagger JP, Morgan K, Beatt KJ. J Am Coll Cardiol; 2010 Feb 02; 55(5):432-40. PubMed ID: 20117456 [Abstract] [Full Text] [Related]
34. Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial". Bach RG, Brooks MM, Lombardero M, Genuth S, Donner TW, Garber A, Kennedy L, Monrad ES, Pop-Busui R, Kelsey SF, Frye RL, BARI 2D Investigators. Circulation; 2014 Apr 22; 129(16):e460-1. PubMed ID: 24753557 [No Abstract] [Full Text] [Related]
36. [Coronary artery surgery in patients with diabetes mellitus]. Lauruschkat AH, Ennker J. Dtsch Med Wochenschr; 2002 Feb 22; 127(8):381-3. PubMed ID: 11859447 [No Abstract] [Full Text] [Related]
37. Cardiovascular disease in diabetes. Sigal R, Malcolm J, Meggison H. Clin Evid; 2002 Jun 22; (7):498-520. PubMed ID: 12230676 [No Abstract] [Full Text] [Related]
39. Effects of heart failure and diabetes mellitus on long-term mortality after coronary revascularization (from the BARI Trial). Holper EM, Brooks MM, Kim LJ, Detre KM, Faxon DP, BARI Investigators. Am J Cardiol; 2007 Jul 15; 100(2):196-202. PubMed ID: 17631069 [Abstract] [Full Text] [Related]
40. Comprehensive Cardiovascular Risk Factor Control Improves Survival: The BARI 2D Trial. Bittner V, Bertolet M, Barraza Felix R, Farkouh ME, Goldberg S, Ramanathan KB, Redmon JB, Sperling L, Rutter MK, BARI 2D Study Group. J Am Coll Cardiol; 2015 Aug 18; 66(7):765-773. PubMed ID: 26271057 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]